General description
Nilotinib is a BCR-ABL tyrosine kinase inhibitor used in treatment protocols for chronic myeloid leukaemia
INN
Nilotinib
ATC codes
Medicine type
Chemical agent
EML status history
First added in 2017
(TRS
1006)
for
Chronic myeloid leukaemia, not elsewhere classified
Wikipedia
DrugBank
Recommendations
Section
Targeted therapies
- Oral > Solid: 150 mg capsule; 200 mg capsule